Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole maintenance treatment in adolescents with schizophrenia
2010-020987-39Phase 3
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in schizophrenia comparing Aripiprazole with Placebo (2 arms). Primary endpoint: Time from randomization to exacerbation of psychotic symptoms or impending relapse.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2010-020987-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020987-39.